Medications & treatment options

Bariatric Surgery, Endoscopic Procedures & GLP-1s

For some patients the decision is not which GLP-1 to take but whether a procedure is the better tool. This cluster collects the articles on bariatric surgery, endoscopic sleeve gastroplasty, and intragastric balloons — published outcomes, cost, insurance, reversibility — and on using GLP-1s before or after a procedure.

18 research articles · newest update October 2026

Recently updated

Bariatric Surgery vs GLP-1 vs Combination: A Decision Guide With 13 Verified Trials

STAMPEDE, Mingrone, ARMMS-T2D, GATEWAY, Adams, STEP-1, SURMOUNT-1, BARI-OPTIMISE — what 13 PubMed-verified primary trials say about bariatric surgery vs GLP-1 medication vs the combination, plus the 2022 ASMBS/IFSO eligibility guidelines, the surgical mortality + complication data, and the honest answer to 'is there a head-to-head RCT' (no, not yet — Cleveland Clinic NCT06803888 is enrolling).

14 min read · Updated August 2026

Bariatric Surgery vs GLP-1s in 2026: Cost, Insurance Coverage, and Long-Term Outcomes

9,650+ monthly searches ask whether bariatric surgery or GLP-1 receptor agonists are the right answer for obesity. We walk through the NIH 1991 and ASMBS 2022 eligibility criteria, the STAMPEDE trial (Schauer 2017), SLEEVEPASS and SM-BOSS, the Swedish Obese Subjects long-term mortality data (Sjöström 2007), the Adams 2007 NEJM cohort, the SPLENDID cancer outcomes (Aminian 2022), Medicare NCD 100.1, and the cost reality.

16 min read · Updated August 2026

Endoscopic (Non-Surgical) Weight-Loss Options: ESG, Balloon, and GLP-1 Compared

Endoscopic bariatric therapy sits between GLP-1 drugs and surgery. ESG produced 13.6% weight loss in the MERIT trial and holds near 16% at 5 years; the intragastric balloon gives ~7-15% over 6 months. How the incisionless options compare to each other, to GLP-1s, and to surgery.

12 min read · Updated August 2026

Endoscopic Sleeve Gastroplasty (ESG): The Evidence vs GLP-1s and Surgery

Endoscopic sleeve gastroplasty (ESG) is an incisionless stomach-tightening procedure that produced 13.6% weight loss in the MERIT randomized trial - on par with semaglutide, below tirzepatide and surgery. The honest evidence on efficacy, safety, cost, reversibility, and how it compares to a GLP-1.

12 min read · Updated August 2026

All 18 articles in this topic

Most recently updated first.